Clinical Trial

AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

Study acronym: DECIDE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 14, 2025 (before its estimated March 27, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of HeartFlow's DECIDE Registry is to collect observational data about the management of patients before and after HeartFlow Artificial Intelligence-Quantitative Coronary Plaque Analysis (AI-QCPA).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-17; most recent amendment 2025-10-09.
Status change: Enrolling by Invitation → Active, Not Recruiting 2025-10-09
Trial Details
NCT Number NCT06376851
Lead Sponsor HeartFlow, Inc.
Conditions Coronary Artery Disease
Enrollment 20,000 participants
Start Date 2024-03-27
Primary Completion 2026-03-27 (estimated)
Study Completion 2030-03-27 (estimated)
Updated on ClinicalTrials.gov 2025-10-14